ArticleFrontiers in physiology2025

Pyridoxamine reduces inflammatory and microcirculatory abnormalities in metabolic dysfunction-associated steatohepatitis and modulates key factors in the hepatic AGE/ALE signaling pathway.

Raquel Rangel Silvares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.